Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New PEG based artificial tear vs Optive in contact lens wearers
NCT00570843Phase 4Completed
- Sponsor
- BP Consulting
- Start
- Mar 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of New PEG based artificial tear in dry eye syndrome (DED), sponsored by BP Consulting. Primary endpoint: Comfort at 1 month. Started Mar 2008; status: completed.
02
Drugs
New PEG based artificial tear
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00570843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570843.